CRISPR-Cas9 Gene-Editing Therapy for Sickle Cell Disease: A Revolutionary Breakthrough
Sickle cell disease (SCD) is a debilitating genetic condition affecting millions worldwide. Characterized by the production of abnormal hemoglobin, it leads to misshapen red blood cells that resemble a sickle. These malformed cells can block blood flow, causing severe pain, organ damage, and reduced life expectancy. For decades, treatment options for SCD have been limited […]
CRISPR-Cas9 Gene-Editing Therapy for Sickle Cell Disease: A Revolutionary Breakthrough Read More »